Zurich Cantonal Bank
AMRX icon

Zurich Cantonal Bank’s Amneal Pharmaceuticals AMRX Stock Holding History

Zurich Cantonal Bank’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-68,137
Closed -$859K – 2601
2025
Q4 		$859K Buy
+68,137
New +$780K ﹤0.01% 1430

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Zurich Cantonal Bank's AMRX Position: Q2 2026 in Review

Zurich Cantonal Bank held its Amneal Pharmaceuticals (AMRX) position steady in Q2 2026 at 100,944 shares worth $1.75M. The position accounts for ﹤0.01% of the portfolio, ranked #1215.

Zurich Cantonal Bank first reported a position in AMRX in Q3 2018 and has held it in 29 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Zurich Cantonal Bank held 100,944 shares of Amneal Pharmaceuticals worth $1.75M as of Q2 2026.
  • Zurich Cantonal Bank left its Amneal Pharmaceuticals share count unchanged in Q2 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1215 holding.
  • Zurich Cantonal Bank first reported a position in Amneal Pharmaceuticals in Q3 2018 and has held it in 29 quarters since.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.